Pu Liao
- Molecular Biology
- Infectious Diseases top 10%
- Cardiology and Cardiovascular Medicine
- Epidemiology
- Biomedical Engineering
- Co-authors
- Yibin WangShi‐Qiang WangRui‐Ping XiaoHeping ChengShengjun ZhangMeizi ZhengMing ZhengSu Wang
- Topics
- COVID-19 Clinical Research Studies (4 papers)SARS-CoV-2 and COVID-19 Research (3 papers)Sepsis Diagnosis and Treatment (3 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONECirculation Research
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Pu Liao
22 papers receiving 426 citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 171
- Infectious Diseases 147
- Cardiology and Cardiovascular Medicine 88
- Epidemiology 72
- Biomedical Engineering 40
Countries citing papers authored by Pu Liao
This map shows the geographic impact of Pu Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pu Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pu Liao more than expected).
Fields of papers citing papers by Pu Liao
This network shows the impact of papers produced by Pu Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pu Liao. The network helps show where Pu Liao may publish in the future.
Co-authorship network of co-authors of Pu Liao
This figure shows the co-authorship network connecting the top 25 collaborators of Pu Liao. A scholar is included among the top collaborators of Pu Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pu Liao. Pu Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 9 | |
| 4 | 17 | |
| 5 | 9 | |
| 6 | 6 | |
| 7 | 27 | |
| 8 | 29 | |
| 9 | 15 | |
| 10 | 69 | |
| 11 | 18 | |
| 12 | 4 | |
| 13 | 6 | |
| 14 | 5 | |
| 15 | 14 | |
| 16 | 7 | |
| 17 | 15 | |
| 18 | 5 | |
| 19 | 0 | |
| 20 | 6 |
About Pu Liao
Pu Liao is a scholar working on Infectious Diseases, Endocrinology and Epidemiology, having authored 23 papers that have together received 436 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Sepsis Diagnosis and Treatment (3 papers). The work is most often cited by research in Infectious Diseases (147 citations), Cardiology and Cardiovascular Medicine (88 citations) and Endocrinology (13 citations). Pu Liao has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yibin Wang, Shi‐Qiang Wang, Rui‐Ping Xiao, Heping Cheng, Shengjun Zhang, Meizi Zheng, Ming Zheng, Su Wang, Yuan Xu and Huan Yang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.